Minerva
Minerva
BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.a442 (Published 26 June 2008) Cite this as: BMJ 2008;336:1512
- Caroline Angit, specialist registrar,
- Loma Gardner, specialist registrar,
- Ian Coulson, consultant dermatologist
- 1department of dermatology, Burnley General Hospital, Burnley BB10 2PQ
- carolineangit{at}hotmail.co.uk
A 40 year old woman with rheumatoid arthritis had received etanercept, a tumour necrosis factor (TNF) antagonist, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.